Literature DB >> 11091100

Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida).

K Suetsuna1, T Nakano.   

Abstract

A peptide fraction having activity against angiotensin I-converting enzyme (ACE) was separated from the peptic digest of protein prepared from wakame (Undaria pinnatifida) by ion-exchange chromatographies and gel-filtration. Fractions with high ACE inhibitory activity were combined and further chromatographed on a reverse-phase column to yield four tetrapeptides with ACE inhibitory properties. These tetrapeptides were identified by sequence analysis and fast atom bombardment mass spectrometry as Ala-Ile-Tyr-Lys (IC(50): 213 microM), Tyr-Lys-Tyr-Tyr (64.2 microM), Lys-Phe-Tyr-Gly (90.5 microM), and Tyr-Asn-Lys-Leu (21 microM). Each tetrapeptide was synthesized and its antihypertensive activity was determined after oral administration in spontaneously hypertensive rats. The blood pressure significantly decreased after tetrapeptide ingestion. The present study demonstrated that dietary wakame may have beneficial effects on hypertension.

Entities:  

Year:  2000        PMID: 11091100     DOI: 10.1016/s0955-2863(00)00110-8

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  23 in total

Review 1.  The role of nutrition and nutraceutical supplements in the treatment of hypertension.

Authors:  Mark Houston
Journal:  World J Cardiol       Date:  2014-02-26

2.  Optimization of some conditions of Neutrase-catalyzed plastein reaction to mediate ACE-inhibitory activity in vitro of casein hydrolysate prepared by Neutrase.

Authors:  Wei Xu; Bao-Hua Kong; Xin-Huai Zhao
Journal:  J Food Sci Technol       Date:  2011-08-24       Impact factor: 2.701

3.  Bioactive L acidissima protein hydrolysates using Box-Behnken design.

Authors:  Sachin K Sonawane; Shalini S Arya
Journal:  3 Biotech       Date:  2017-07-03       Impact factor: 2.406

4.  First Report of Screening of Novel Angiotensin-I Converting Enzyme Inhibitory Peptides Derived from the Red Alga Acrochaetium sp.

Authors:  Seto Windarto; Meng-Chou Lee; Happy Nursyam; Jue-Liang Hsu
Journal:  Mar Biotechnol (NY)       Date:  2022-09-08       Impact factor: 3.727

5.  Angiotensin-I-Converting Enzyme Inhibitory Activity of Protein Hydrolysates Generated from the Macroalga Laminaria digitata (Hudson) JV Lamouroux 1813.

Authors:  Diane Purcell; Michael A Packer; Maria Hayes
Journal:  Foods       Date:  2022-06-17

Review 6.  Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.

Authors:  Isuru Wijesekara; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

Review 7.  Nutrition and nutraceutical supplements for the treatment of hypertension: part III.

Authors:  Mark Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-01       Impact factor: 3.738

8.  Seaweed intake and blood pressure levels in healthy pre-school Japanese children.

Authors:  Keiko Wada; Kozue Nakamura; Yuya Tamai; Michiko Tsuji; Yukari Sahashi; Kaori Watanabe; Sakiko Ohtsuchi; Keiko Yamamoto; Kyoko Ando; Chisato Nagata
Journal:  Nutr J       Date:  2011-08-10       Impact factor: 3.271

9.  Investigation of Chlorella pyrenoidosa Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides.

Authors:  Yuchen Li; Gilda Aiello; Enrico Mario Alessandro Fassi; Giovanna Boschin; Martina Bartolomei; Carlotta Bollati; Gabriella Roda; Anna Arnoldi; Giovanni Grazioso; Carmen Lammi
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

Review 10.  Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods.

Authors:  Susana M Cardoso; Olívia R Pereira; Ana M L Seca; Diana C G A Pinto; Artur M S Silva
Journal:  Mar Drugs       Date:  2015-11-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.